Context.-When adenocarcinomas arise within the esophagus, particularly when located away from the gastroesophageal junction, it may be important in some patients to differentiate between a primary esophageal adenocarcinoma and metastasis from another site. Lung adenocarcinoma is one tumor that has been reported to frequently metastasize to the esophagus.Objectives.-To create a panel of immunohistochemical markers that can reliably distinguish between an esophageal and pulmonary primary; within the gastrointestinal pathology literature, including published articles and textbooks, common lung immunohistochemical markers, such as TTF-1, are assumed to be negative in esophageal adenocarcinoma, yet, to our knowledge, no study has yet investigated the veracity of that presumption.Design.-In this study, 24 cases each of pulmonary and esophageal adenocarcinomas were stained with TTF-1, napsin A, CDX2, 34bE12, N-cadherin, and IMP3 in an attempt to define an optimal panel for differentiation. Esophageal adenocarcinomas occurring at the gastroesophageal junction were excluded in this study because a gastric primary tumor cannot be excluded in those cases.Results.-Surprisingly, TTF-1 and napsin A were positive in similar proportions of tumors from both sites. Those markers that differentiated statistically between esophageal and pulmonary adenocarcinoma were IMP3, CDX2, and N-cadherin.Conclusions.-When differentiating the origin of a tumor as either esophageal or pulmonary, an immunohistochemical panel consisting of IMP3, CDX2, and Ncadherin is superior to either TTF-1 or napsin A.(Arch Pathol Lab Med. 2013;137:1094-1098; doi: 10.5858/arpa.2012-0305-OA) M alignant tumors frequently involve multiple organ systems, either by direct extension or by metastasis. Moreover, adenocarcinomas from various sites can be morphologically similar, necessitating immunohistochemical examination to accurately determine the site of origin. Distinguishing a primary site when adenocarcinomas involve both the esophagus and lungs can be difficult. Tumors in these organs may metastasize or can invade via direct extension because of the close proximity of the involved organs.Metastasis to the esophagus is not an uncommon occurrence. However, certain tumors have been documented to metastasize to the esophagus more frequently than others, including lung, thyroid, breast, and ovary. In a study of 1835 autopsy cases of patients who died from carcinomas, metastases to the esophagus occurred in 112 cases (6.1%). The lung was the most common primary site, representing 51 of 112 cases (45.5%) of esophageal metastases. Of these 51 cases, 32 (63%) were adenocarcinoma and 19 (37%) were squamous cell carcinoma.1 Because of the histomorphologic similarities, distinguishing the exact site of a primary tumor can be exceedingly difficult and is critical because the treatment regimens differ depending on the tissue origin.Thyroid transcription factor-1 (TTF-1) protein has historically been a reliable marker of pulmonary adenocarcinoma and thyroid malignancies. Init...